Skip to content

Comparison of the analgesic effect of bupivacaine liposome with ropivacaine in erectile ridge muscle plane block after hepatectomy: a randomized, controlled, double-blind clinical study

Comparison of the analgesic effect of bupivacaine liposome with ropivacaine in erectile ridge muscle plane block after hepatectomy: a randomized, controlled, double-blind clinical study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089125
Enrollment
Unknown
Registered
2024-09-02
Start date
2024-09-11
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after hepatectomy

Interventions

Bupivacaine liposomes:Erector spinal muscle block combined with bupivacaine liposomes in hepatectomy patients
ropivacaine:Erector spinal block combined with ropivacaine in patients with hepatectomy

Sponsors

The First Bethune Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients aged 18 to 80 years who have undergone hepatectomy and are in ASA grades I to III.

Exclusion criteria

Exclusion criteria: Patients with puncture site infection and damage, cognitive impairment, allergy to narcotic drugs, renal failure, liver failure, history of opioid abuse, and peripheral neuropathy. Patients refusing to sign informed consent to participate in the study; Other conditions deemed inappropriate by the investigator to participate in the study.

Design outcomes

Primary

MeasureTime frame
NRS pain score at rest 3 hours after surgery;

Secondary

MeasureTime frame
VAS pain scores during rest and exercise at 12, 24, 48, and 72 hours postoperatively;Total consumption of analgesic drugs administered 72 hours after surgery;The usage time of the analgesic pump;

Countries

China

Contacts

Public ContactLi Zhiwen

The First Bethune Hospital of Jilin University

3050341774@qq.com+86 188 4317 7788

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026